Rebalix
Logo InvescoInvesco · sheet of 4 September 2026
ETF sheet · official issuer and register data

Invesco S&P 500 Scored & Screened UCITS ETF Acc

5ESG · IE00BKS7L097 · class Acc · USD · domicile Ireland
Equity · United States · Large cap · Sustainable / ESGSFDR art. 8
Index tracked: S&P 500 Scored & Screened NTR Index
TER
0.09%+ trans. 0.11%
Fund size
3.7 bn EUR
Tracking difference
not computable
🇮🇹 tax rate
26.00%white list 0.00%
Replication
Synthetic (swap)
Income
Accumulating
Launch 9 Mar 2020 · costs from the KID as of 14 Aug 2026 · 274 securities held · 9 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 2 Sept 2026
Investment objective: The objective of the Fund is to achieve the net total return performance of the S&P 500 Scored & Screened Index (the "Index"), less fees, expenses and transaction costs. Dividend Policy: This Share Class does not pay you income, but instead reinvests it to grow your capital, in line with its stated objectives. Investment approach: The Fund is a passively managed ETF. To achieve the objective the Fund will use unfunded swaps ("Swaps"). These Swaps are an agreement between the Fund and an approved counterparty to exchange one stream…

Performance since series start (in euro) — base 100

9 Mar 20203 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
20212022202320242025202632387319
High 323 (13 Aug 2026) · low 87 (23 Mar 2020) · last 319. Past performance is not indicative of future results.

Returns in euro

1 year+25.2%
3 years+66.0%
5 years+92.9%
10 yearsseries too young
Since series start+218.8%

Risk · 1 / 3 / 5 years

Volatility (ann.)13.09%15.10%17.23%
Max drawdown−9.50%−19.25%−24.70%
Sharpe1.551.160.69
Sortino2.321.721.00
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · 5ESG · IE00BKS7L0971
Rebalix5ESG · IE00BKS7L097 · sheet of 4 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years
Not honestly computable: under review: anomalies in the fund or index series

Holdings

Synthetic replication: top positions of the substitute basket (swap collateral), not the fund’s exposure · 31 Aug 2026 · 274 securities · top-10 weight = 31.5%
Top holdingsWeight
MICRON TECHNOLOGY INC5.6%
NVIDIA CORP5.2%
UNITEDHEALTH GROUP INC4.1%
MICROSOFT CORP4.0%
LAM RESEARCH CORP3.4%
ELI LILLY & CO2.1%
NOVARTIS AG-REG2.0%
MERCADOLIBRE INC1.7%
CISCO SYSTEMS INC1.7%
SALESFORCE INC1.7%

Listing venues

ESMA register (FIRDS) and official exchange lists
5ESG · Borsa Italiana (ETFplus), Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 20 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · www.invesco.com/content/dam/invesco/emea/en/product-documents/etf/shar
Factsheet · www.invesco.com/content/dam/invesco/emea/en/product-documents/etf/shar
Prospectus · www.invesco.com/content/dam/invesco/emea/en/product-documents/etf/umbr
The live sheet, always up to date
rebalix.com/en/etf/IE00BKS7L097
Series, distributions, holdings and documents refresh daily.
Sheet produced on 4 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · 5ESG · IE00BKS7L0972